16th week of 2012 patent applcation highlights part 39 |
Patent application number | Title | Published |
20120093869 | LIVE-ATTENUATED COMPOSITIONS FOR BACTERIAL INFECTIONS - The present invention relates to compositions and methods for disease treatment and prevention through administration of a live attenuated composition. In particular, the present invention provides compositions and methods for the treatment and prevention of urinary tract infection by administration of a live attenuated compositions lacking O-antigen ligase activity. | 2012-04-19 |
20120093870 | ATTENUATED ENTEROHEMORRHAGIC E.COLI-BASED VACCINE VECTOR AND METHODS RELATING THERETO - An attenuated enterohemorrhagic | 2012-04-19 |
20120093871 | MODIFIED PROTOZOAN EXPRESSING AT LEAST TWO VARIABLE SURFACE PROTEINS (VSP), A VACCINE COMPRISING IT AND PROCEDURES, USES, AND METHODS THEREOF - Modified protozoa parasites comprising simultaneous expression on its surface of at least two ariable surface proteins (VSP). The modified protozoa may also simultaneously express the complete repertoire of variable surface proteins. Protozoa show reduced expression of Dicer, RNA-dependant RNA-plymerase (RdRP) enzymes or both, wherein the RdRP gene and/or the Dicer gene has been silenced. The protozoan may be any protozoan showing an antigenic variation mechanism. | 2012-04-19 |
20120093872 | Method For Polypeptide Transfer Into Cells - The present invention relates to a method for polypeptide transfer into cells. The present invention further relates to the detection of polypeptide-specific immune cells and the priming, expansion and reactivation of polypeptide-specific T cells. Moreover the present invention relates to polypeptides of the methods of the present invention in combination with urea and their use for research, diagnosis or treatment and prevention of diseases in animals and humans. | 2012-04-19 |
20120093873 | Molecular Interactions in Hematopoietic Cells - The invention provides reagents and methods for inhibiting or enhancing interactions between proteins in hematopoietic cells and other cells involved in the mediation of an immune response. Reagents and methods provided are useful for treatment of a variety of diseases and conditions mediated by immune system cells. | 2012-04-19 |
20120093874 | METHOD FOR SCREENING FOR DIET PROVIDING PRODUCTION OF MILK HAVING IMMUNOREGULATORY ACTION - A method for screening for a foodstuff providing production of milk having an immunoregulatory action, a novel foodstuff having an immunoregulatory action, and a method for producing it are provided. A diet or substance that increases or decreases an amount of microRNA present in milk of a mammal is identified by using correlation of microRNA profiles in the milk and a diet ingested by the mammal or a substance contained in the diet as an index to screen for a diet or a substance providing production of breast milk having an immunoregulatory action. | 2012-04-19 |
20120093875 | AMINOCYCLITOL COMPOUNDS, PROCESS FOR OBTAINING THEM AND USES - Aminocyclitol compounds and uses thereof as pharmaceutical compositions for the treatment of diseases associated with alterations in iNKT cells, more specifically autoimmune diseases, cancer, infections caused by pathogenic microorganisms or inflammatory diseases. Furthermore, the invention relates to the process for obtaining said compounds. | 2012-04-19 |
20120093876 | Ophthalmic Formulations, Methods Of Manufacture And Methods of Normalizing Meibomian Gland Secretions - The present invention provides process for producing non-aqueous compositions for normalizing meibomian gland secretions. The present invention further provides compositions and methods for treating and/or preventing the signs and/or symptoms of dry eye disease. | 2012-04-19 |
20120093877 | COLLAGEN SCAFFOLD FOR CELL GROWTH AND A METHOD FOR PRODUCING SAME - A bioscaffold and method of manufacture is described. The bioscaffold comprised greater than 80% type I collagen fibers or bundles having a knitted structure providing tensile load strength. The method of manufacture comprises the steps of: (a) isolating collagen fibers or bundles; (b) incubating said fibers or bundles in a mixture of NaOH, alcohol, acetone, HC; and ascorbic acid; and (c) mechanical manipulation of said fibers or bundles to produce a knitted structure. | 2012-04-19 |
20120093878 | PHARMACEUTICAL COMPOSITIONS CONTAINING A BIGUANIDE AND A THIAZOLIDINEDIONE - The present invention relates to pharmaceutical compositions that include a combination of a biguanide present in an extended-release form and a thiazolidinedione present in an immediate-release form. The present invention further relates to the processes for preparing such compositions. | 2012-04-19 |
20120093879 | CARDIAC STEM CELLS AND USES OF SAME IN CARDIAC REPAIR - Method for the isolation, expansion and preservation of cardiac stem cells from human or animal tissue biopsy samples to be employed in cell transplantation and functional repair of the myocardium or other organs. Cells may also be used in gene therapy for treating cardiomyopathies, for treating ischemic heart diseases and for setting in vitro models to study drugs. | 2012-04-19 |
20120093880 | METHOD AND KIT FOR TOPICAL ELIMINATION OF PSORIATIC LESIONS WITH A CAUSTIC APPLICATOR - A method and kit for eliminating a psoriatic lesion involves removal of loose psoriatic scales if present, and moistening remaining scales to a depth to or just above epidermal tissue underlying the scales. The hydrated scales are then contacted with a dry composition of from about 50% to about 95% silver nitrate using a specially configured applicator such that a portion of the moisture of the hydrated psoriatic scales will be absorbed into the dry composition so as to dissolve an outer layer of the silver nitrate into a solution. The solution will then be absorbed into the psoriatic scales to the depth of the moistening thereof to chemically cauterize the moistened scales. The method can be repeated until elimination is achieved. Cauterization of surrounding and underlying tissue is undesirable, and if contacted by moisture, dehydration can be allowed, and the lesion rehydrated as necessary. | 2012-04-19 |
20120093881 | DISRUPTIVE POLYMER MICELLE COMPOSITION - A pharmaceutical composition containing a drug encapsulated in a polymer micelle composition containing a first block copolymer having affinity with HDL and a second block copolymer having affinity with a lipoprotein excluding HDL, each block copolymer having a hydrophobic polymer chain segment and a hydrophilic polymer chain segment such that a plurality of block copolymers arrange radially with the hydrophobic segments directed inward and the hydrophilic segments directed outward. In the composition, a detachment of the first block copolymer is induced by HDL adhesion which forms a gap and promotes the release of a drug encapsulated, while the second block copolymer excluding an affinity with HDL controls a release speed of the drug encapsulated. | 2012-04-19 |
20120093882 | STABLE PHARMACEUTICAL COMPOSITIONS OF DICLOFENAC - The present invention discloses a stable pharmaceutical composition of diclofenac or salts thereof comprising nano size droplets of diclofenac or salts thereof, wherein the composition exhibits a significant difference in one or both of the rate and extent of absorption of diclofenac or salts thereof as compared to formulation of diclofenac marketed under the trade name Voveran® | 2012-04-19 |
20120093883 | METHOD OF TREATING AND PREVENTING NEURO-OLFACTORY TRIGGERED OR AGGRAVATED ILLNESSES OR RELATED CONDITIONS - A method for treating at least one of neuro-olfactory triggered illnesses, and related conditions within a subject is provided. The method includes the steps of: a) providing a composition that includes one or more agents adapted to induce a level of anosmia/hyposmia in the subject, which level of anosmia/hyposmia is sufficient to substantially decrease olfactory sensory stimulation within the subject and a neurologic response to the stimulation that is one or both of triggering and aggravating the illness or condition; and b) applying the composition to a nasopharynx region of the subject. | 2012-04-19 |
20120093884 | NOROVIRUS CAPSID AND ROTAVIRUS VP6 PROTEIN FOR USE AS COMBINED VACCINE - The present invention relates to a combined norovirus and rotavirus vaccine for prevention of norovirus and rotavirus infection and/or viral-induced diarrheal and vomiting diseases in man. More specifically, the invention comprises a method of preparing combination vaccine compositions comprising norovirus and rotavirus antigens, in particular mixtures of norovirus VLPs and rotavirus recombinant VP6 protein or double-layered VP2/VP6 VLPs. In addition, the invention relates to methods of inducing an immune response. | 2012-04-19 |
20120093885 | THERAPEUTIC VESICLES - The present technology provides compositions of vesicles, uses of vesicles, and methods relating to vesicles. For example, provided herein are vesicles derived from stem cells for use in regenerative therapies. | 2012-04-19 |
20120093886 | PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY - The pharmaceutical compositions described herein include a suspension which comprises an admixture in solid form of a therapeutically effective amount of a therapeutic agent and at least one salt of a medium chain fatty acid and a hydrophobic medium, e.g. castor oil or glyceryl tricaprylate or a mixture thereof. The pharmaceutical compositions described herein contain medium chain fatty acid salts and are substantially free of alcohols. The pharmaceutical compositions may be encapsulated in a capsule. Methods of treating or preventing diseases by administering such compositions to affected subjects are also disclosed. | 2012-04-19 |
20120093887 | AMORPHOUS VARENICLINE TARTRATE CO-PRECIPITATES - Disclosed herein is a stable amorphous coprecipitate comprising varenicline tartrate and a pharmaceutically acceptable excipient selected from the group consisting of maltodextrin, lactose monohydrate and 2-hydroxypropyl-β-cyclodextrin, method for the preparation, pharmaceutical compositions, and method of treating thereof. Advantageously, the amorphous coprecipitates of varenicline tartrate disclosed herein have improved physiochemical characteristics that assist in the effective bioavailability. | 2012-04-19 |
20120093888 | MICRO-EMULSIONS FOR THE TREATMENT OF RHEUMATIC DISORDERS - A formulation to treat rheumatic disorders and related infections is provided. The formulation is a micro-emulsion including at one or more of an active ingredients. The active ingredient includes one or more of an essential oil mixed with an aqueous phase along with one or more of a surfactant and one or more of a co-surfactant. The co-surfactant is medicated by an extract of one or more of an herb. | 2012-04-19 |
20120093889 | LAYERED PHARMACEUTICAL FORMULATIONS - In one embodiment a layered pharmaceutical formulation includes two or more pharmaceutical layers and an intermediate layer disposed between at least two of the two or more pharmaceutical layers, the intermediate layer configured to dissolve in vivo to thereby leave the two or more pharmaceutical layers substantially intact. In one embodiment, an active pharmaceutical ingredient in at least one of the pharmaceutical layers is selected from bupropion, zonisamide, naltrexone, topiramate, phentermine, metformin, olanzapine and fluoxetine. | 2012-04-19 |
20120093890 | INHALABLE AZTREONAM FOR TREATMENT AND PREVENTION OF PULMONARY BACTERIAL INFECTIONS - A method and a composition for treatment of pulmonary bacterial infections caused by gram-negative bacteria suitable for treatment of infection caused by | 2012-04-19 |
20120093891 | MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE - The present invention provides a pharmaceutical composition comprising a pharmaceutically acceptable excipient and a compound of the formula: | 2012-04-19 |
20120093892 | MINOCYCLINE ORAL DOSAGE FORMS FOR THE TREATMENT OF ACNE - Minocycline oral dosage forms containing a controlled release carrier are useful for the treatment of acne. | 2012-04-19 |
20120093893 | Highly Efficient Delivery of a Large Therapeutic Mass Aerosol - A method for delivering an agent to the pulmonary system, in a single, breath-activated step or a single breath, comprises administering from a receptacle enclosing a mass of particles, to a subject's respiratory tract, particles which have a tap density of less than 0.4 g/cm | 2012-04-19 |
20120093894 | STABLE CYCLOSPORINE CONTAINING OPHTHALMIC EMULSION FOR TREATING DRY EYES - Disclosed herein are stable oil-in-water emulsion ophthalmic topical liquid compositions having an average particle size less than 1 μm including at least one plant-derived oil other than castor oil wherein the oil comprises only aliphatic side chains free of polar pendent groups. The oil-in-water emulsion ophthalmic topical liquid compositions also include a hydrophilic surfactant having an HLB value between approximately 10 and 14, a vegetable oil-derived hydrophobic non-co-block surfactant having unsaturated side chains that contain less than four oxygen atoms having an HLB value between approximately 4 and 6 and is a liquid at room temperature. The oil-in-water emulsion ophthalmic topical liquid compositions disclosed herein can further include an amount of cyclosporine A or polyphenol in an amount effective to relieve dry eye symptoms. | 2012-04-19 |
20120093895 | BONE-REPAIR COMPOSITION - The present invention relates to a bone-repair composition comprising a micro-pulverized demineralized bone matrix; a nonmicro-pulverized demineralized bone matrix; and a hydrating material. The bone-repair composition of the present invention provides easier injectability and shape-maintenance (handling), and exhibits excellent bone-repairing effects due to a large surface area of the micro-pulverized demineralized bone matrix and an early release of the bone growth factors, compared with conventional compositions comprising the nonmicro-pulverized demineralized bone matrix alone. It also has an advantage of being biocompatible and harmless to the human body because there is no use of synthetic materials. | 2012-04-19 |
20120093896 | USE OF NANODISPERSIONS TO PROTECT WATER-SOLUBLE INGREDIENTS IN COSMETIC END FORMULATIONS - The invention describes the use of a nanodispersion, which comprises: a) a membrane-forming molecule, b) a co-emulsifier, c) a lipophilic component, and d) a water-soluble ingredient sensitive to oxidation in cosmetic end formulations, the nanodispersion being obtainable by (α) mixing the components (a), (b) and (c) until a homogeneous liquid is obtained (so-called nanodispersion pre-phase), and (β) adding the water or aqueous phase (discontinuous phase) which contains the water-soluble ingredient and optionally the non-aqueous polar organic solvent to the liquid obtained in step (α). Component (d) is preferably ascorbic acid or vitamin C. | 2012-04-19 |
20120093897 | Skin Engaging Member Comprising An Emollient - A skin engaging member for use with a hair removal device, said skin engaging member comprising: a carrier comprising a pair of opposing sidewalls forming a channel; and at least one skin conditioning composition at least partially contained within said channel, wherein said skin conditioning composition comprising: at least one of a lipid, an emollient hydrocarbon, a lipophilic skin active, and a mixture thereof; and a block polymer selected from the group consisting of: a di-block copolymer, a tri-block copolymer, a multi-block copolymer, a radial block copolymer, a random block copolymer, and mixtures thereof. | 2012-04-19 |
20120093898 | Metal Ion Nanoclusters - A composition containing a plurality of water-soluble nanoclusters ranging from 2 nm to 500 nm in diameter. Each of the nanoclusters contains one or more metal cations, one or more anions, and one or more water-soluble ligands. Also disclosed is a method of using the composition for treating various disorders such as anemia, heartburn, and diabetes. | 2012-04-19 |
20120093899 | Process for Preparing a High Stability Microcapsule Product and Method for Using Same - The present invention is directed to a process for preparing a capsule product through the increase in the polymerization cure temperature and cure time during the capsule-making process. The microcapsule products prepared according the process of the present invention exhibit enhanced retention of active materials in consumer products which promote instability. | 2012-04-19 |
20120093900 | CAPILLARY COMPOSITION FOR TREATING HAIR - The invention relates to a capillary composition comprising at least particles of pumice, at least one silicon containing quaternary ammonium groups, and at least one non-siliconised polymer. | 2012-04-19 |
20120093901 | METHOD FOR PRODUCING FREE POWDER PARTICLES OF POLYAMIDE IMPREGNATED WITH AT LEAST ONE COSMETIC OR PHARMACEUTICAL AGENT, AND FREE POWDER PARTICLES OF POLYAMIDE HAVING A CONTENT OF AT LEAST 25 WT % OF A COSMETIC OR PHARMACEUTICAL AGENT OTHER THAN WATER - The invention relates to a method for producing free powder particles of polyamide impregnated with at least one cosmetic or pharmaceutical agent. The present also relates to free powder particles of polyamide having a content of at least 25% by weight of a cosmetic or pharmaceutical agent other than water, to the use of said particles in cosmetic, pharmaceutical or perfumery products, and to compositions containing such particles. | 2012-04-19 |
20120093902 | FLUID RESERVOIR - Fluid reservoirs which are based on polymer substrates and are capable of storing large amounts of fluids. The storage is reliable and the reemergence from the liquid reservoir is readily controllable, for example, via the temperature or via mechanical actions, to achieve retardation of the fluid release. Also, processes for producing such fluid reservoirs and also their use, for example in washing or cleaning compositions. | 2012-04-19 |
20120093903 | POWDERY OR GRANULATED COMPOSITION COMPRISING A COPOLYMER, A SALT OF A FATTY MONOCARBOXYLIC ACID AND A FATTY MONOCARBOXYLIC ACID AND/OR A FATTY ALCOHOL - The invention relates to a powdery or granulated composition comprising at least by 30% by weight of a mixture of (a) a copolymer composed of polymerized units of C | 2012-04-19 |
20120093904 | COMPOSITION COMPRISING AN ANIONIC POLYMERIC MATERIAL AND THE SALT OF A SATURATED MONOCARBOXYLIC ACID HAVING 6 TO 22 CARBON ATOMS - The invention relates to a coating composition for the coating or binding of pharmaceutically, nutraceutically or cosmetically active ingredients, comprising (a) an anionic polymeric material, and (b) one or more salts of saturated monocarboxylic acids having 6 to 22 carbon atoms, characterized in that the amount of the salts of the monocarboxylic acids in the composition corresponds to 3 to 50 mol percent of the amount of anionic groups in the polymeric material. The invention also relates to a process for preparing a dispersion out of the composition, as well as the use of said composition in enteric-coated solid dosage forms. | 2012-04-19 |
20120093905 | ORAL CARE COMPOSITIONS COMPRISING A POLYMERIC DYE - An oral care composition comprising a dye polymer, for modifying the colour of teeth. | 2012-04-19 |
20120093906 | EMULSIONS, EMULSIFIER, METHOD OF USE AND PRODUCTION PROCESS - Emulsions, emulsifier, a method of use and a production process of said emulsions are presented in the present invention. The emulsion composed of a mixture of water and oils and additives sheared into small droplets using a low pressure, three shearing stage emulsifier. The oils used in the preparation of said emulsions are botanical oils and in most cases, edible oils. | 2012-04-19 |
20120093907 | COMPOSITE OF SILVER NANOPARTICLE AND LAYERED INORGANIC CLAY FOR INHIBITING GROWTH OF SILVER-RESISTANT BACTERIA - The present invention provides a composite of spherical silver nanoparticles and layered inorganic clay. This composite can effectively inhibit the growth of silver-resistant bacteria. The layered inorganic clay serves as carriers of the silver nanoparticles and disperses them. The composite has a particle size of about 5 nm to 100 nm. The silver nanoparticles can be dispersed in an organic solvent or water. | 2012-04-19 |
20120093908 | METAL OXIDE STERILIZING CATALYST, AND STERILIZING DEVICE AND SYSTEM INCLUDING THE SAME - Disclosed is a sterilizing catalyst, a sterilizing device and a sterilizing system, the sterilizing catalyst includes a metal lattice including a metal oxide, and an oxygen vacancy-inducing metal that is integrated or encompassed within the metal lattice. The metal oxide is an oxide of a divalent or multivalent metal. The oxygen vacancy-inducing metal has an oxidation number lower than that of the divalent or multivalent metal. | 2012-04-19 |
20120093909 | Ceramic Coatings and Applications Thereof - In one aspect, the present invention provides coated metal substrates which, in some embodiments, demonstrate one or more advantageous chemical and/or mechanical properties. | 2012-04-19 |
20120093910 | NON-HORMONAL VAGINAL CONTRACEPTIVE - The present invention relates to a non-hormonal, biocompatible, and biodegradable intravaginal device for the delivery of spermiostatic, spermicidal and anti-infectious agents. The present invention also relates to methods of contraception using such a device, as well as the prevention and treatment of sexually transmitted diseases and vaginal infections through the application of the device. | 2012-04-19 |
20120093911 | PLATINUM-CATALYZED INTRAVAGINAL RINGS - The present invention provides improved intravaginal drug delivery devices, i.e., intravaginal rings, useful for the prophylactic administration of an antimicrobial compound, e.g., Dapivirine, to a human. The intravaginal rings of the invention address previous stability issues by utilizing a platinum catalyst (e.g., in the form of a platinum-siloxane complex) for the cross-linking reaction. The vaginal rings surprisingly achieve relatively high and steady release rates in vivo with a matrix ring containing a relatively small loading dose. While the matrix rings of the present invention have in vivo the steady release rates associated with reservoir rings, they are easier and less expensive to manufacture. The present invention also provides methods of blocking DNA polymerization by an HIV reverse transcriptase enzyme, methods of preventing HIV infection in a female human, methods of treating HIV infection in a female human, and methods of preparing platinum-catalyzed intravaginal rings. | 2012-04-19 |
20120093912 | Biomimetic Nanofiber Web And Method And Device To Manufacture The Same - A method for forming nanofiber web comprises the steps of: mixing ( | 2012-04-19 |
20120093913 | Inhibition of SYK kinase expression - The present invention relates, in general, to Syk kinase and, in particular, to a method of inhibiting Syk kinase expression using small interfering RNA (siRNA). | 2012-04-19 |
20120093914 | IMPLANTABLE LIPOSOME EMBEDDED MATRIX COMPOSITION, USES THEREOF, AND POLYCAPROLACTONE PARTICLES AS SCAFFOLDS FOR TISSUE REGENERATION - In various embodiments, the present invention describes materials and methods for the local reprogramming of cells in a location where the treatment is applied. The invention can be used to replace lost cells or to restore function to tissue damaged due to disease, injury or genetic defect. In various embodiments, the treatment includes a semisolid hydrogel embedded with liposomes. The liposomes can contain an effector molecule or molecules. When phagocytic cells such as monocytes infiltrate the hydrogel, they encounter the liposomes and incorporate the liposomes carrying the effector molecules into the cells. In some embodiments, the effector molecules can be genetic material encoding the expression of specific proteins such as transcription factors, the expression of which can initiate the reprogramming of the cells. In other embodiments, the effector molecules can induce angiogenesis. In other embodiments, the effector molecules are tumor antigens. The matrix can contain other effector molecules designed to attract specific cells to the matrix. The cells can be released from the matrix as the matrix degrades or by active migration from the matrix. The cells can also remain in the matrix and secret molecules such as proteins and hormones that will diffuse through the matrix material to the surrounding tissue. | 2012-04-19 |
20120093915 | VECTORS INCLUDING AN ANIONIC MACROMOLECULE AND A CATIONIC LIPID FOR DELIVERING SMALL NUCLEIC ACIDS - The invention relates to a composition including (1) an anionic macromolecule except nucleic acids, (2) a cationic lip, and (3) a nucleic acid having a size lower than or equal to 200 nucleotides, such as an interference RNA, and to the use thereof in gene therapy. | 2012-04-19 |
20120093916 | Devices, Systems and Methods for Improving Memory and/or Cognitive Function Through Brain Delivery of SIRNA - The present invention relates to devices, systems, and methods for improving memory and/or cognitive function by brain delivery of compositions of small interfering RNA or vectors containing the DNA encoding for small interfering RNA. Such compositions can be administered using devices, systems and methods for direct delivery of the compositions to the brain, or using devices, systems, methods of delivery, and compositions that deliver small interfering RNA or vectors containing the DNA encoding the small interfering RNA across the blood-brain barrier. The present invention also provides valuable small interfering RNA vectors, and methods for reduction of BACE1 levels in the hippocampus, cerebral cortex, or other regions of the brain that have beneficial effects on improving memory and/or cognitive function in a subject. | 2012-04-19 |
20120093917 | METNASE AND INTNASE INHIBITORS AND THEIR USE IN TREATING CANCER - This invention relates to novel cancer treatment compositions and associated therapeutic methods. More particularly, this invention relates in part to small chemical inhibitors of DNA repair proteins (Metnase) and to a therapeutic method that utilizes the inhibitors to increase the effectiveness of cancer treatment protocols. | 2012-04-19 |
20120093918 | COMPOSITIONS COMPRISING A RADIOSENSITIZER AND AN ANTI-CANCER AGENT AND METHODS OF USES THEREOF - A combination of an anti-cancer agent and a metal radiosensitizer potentiates the radiotherapy of cancer. Said anti-cancer agent is preferably cisplatin while the metal radiosensitizer is preferably gold nanoparticles. Both the anti-cancer agent and the metal radiosensitizer bind to DNA and potentiate the radiotherapy of cancer by synergistically increases the amount of double strand breaks induced by the radiation. The anti-cancer agent and the metal radiosensitizer may be encapsulated in liposomes. | 2012-04-19 |
20120093919 | E2F AS A TARGET OF HORMONE REFRACTORY PROSTATE CANCER - The instant invention provides amino acid sequences competing with E2F for DNA binding. Methods of using said amino acid sequences for treatment of hormone-refractory prostate cancer are also provided. | 2012-04-19 |
20120093920 | METHOD OF TREATMENT FOR BLADDER DYSFUNCTION - Liposomes are used for intravesical drug delivery, especially delivery of botulinum toxin (BoNT) to help improve lower urinary tract symptoms by decreasing bladder irritation and frequency. The system uses a lower and safer dose of BoNT with lower risk of urinary retention. A simple instillation of liposome-BoNT as a liquid formulation into the bladder, in a typical volume of 30-60 ml, will achieve efficacy similar to that currently achieved with cystscopic needle injection of BoNT. The dose may be lower than that done by injection, thereby causing significantly less risk of urinary retention. Liposome-BoNT can protect the BoNT from bladder and urine breakdown. Liposome-BoNT instillation is more comfortable for the patients and allows many more doctors' offices to offer this form of treatment that would otherwise be restricted to doctors skilled and certified in cystoscopic BoNT injection. | 2012-04-19 |
20120093921 | IMMUNOGENIC COMPOSITIONS HAVING LOW SODIUM CHLORIDE CONCENTRATION - Immunogenic compositions comprising an antigen, wherein the concentration of sodium chloride or the ionic strength of the composition is less than 100 mM, and their use in medicine, are provided. | 2012-04-19 |
20120093922 | PHARMACEUTICAL COMPOSITIONS COMPRISING EPA AND A CARDIOVASCULAR AGENT AND METHODS OF USING THE SAME - The present invention relates to, inter alia, pharmaceutical compositions comprising EPA and one or more cardiovascular agents, and to therapeutic methods for treating various diseases and disorders using the same. | 2012-04-19 |
20120093923 | Apparatus And Methods For Delivering A Plurality Of Medicaments For Management Of Co-Morbid Diseases, Illnesses, Or Conditions - A method and apparatus for delivering a plurality of medicaments in a single delivery vehicle for the management of co-morbid diseases, illnesses and conditions. The present invention provides a novel delivery process for many medicaments. Medicaments may be encapsulated and stored separately within a larger capsule until the time of ingestion, consumption, or the like. Benefits of the present invention include maintaining separation of distinct ingredients within a single capsule and the capability to control the time release of multiple ingredients within the capsule. | 2012-04-19 |
20120093924 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA - In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. | 2012-04-19 |
20120093925 | ORAL MEDICINAL COMPOSITION AND ORAL MEDICINAL CAPSULE HAVING THE COMPOSITION ENCAPSULATED THEREIN - The present invention relates to an oral medicinal composition comprising (a) a medical agent that is low in solubility in both water and oils but is soluble in a polyethylene glycol, (b) a polyethylene glycol that is solid at temperatures of 40° C. or lower, and (c) an oily or aqueous auxiliary agent. The oral medicinal composition cannot provide any stimulus or unpleasant feeling during being dissolved in the mouth, and is improved in the solubility of the medicinal agent in the mouth, and is also improved in the absorbability of the medicinal agent in the mouth. | 2012-04-19 |
20120093926 | GASTRIC RESISTANT PHARMACEUTICAL OR NUTRACEUTICAL FORMULATION COMPRISING ONE OR MORE SALTS OF ALGINIC ACID - The invention relates to a gastric resistant pharmaceutical or nutraceutical composition, comprising a core, comprising a pharmaceutical or nutraceutical active ingredient and a gastric resistant coating layer onto the core, wherein the release of the pharmaceutical or nutraceutical active ingredient is not more than 15% under in-vitro conditions at pH 1.2 for 2 hours in medium according to USP with and without the addition of 40% (v/v) ethanol, wherein the gastric resistant coating layer comprises 10 to 100% by weight of one or more salts of alginic acid with a viscosity of 30 to 720 cP of a 1% aqueous solution | 2012-04-19 |
20120093927 | 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-y- lidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) - Disclosed are novel pharmaceutical compositions containing 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine) (eltrombopag olamine) and processes for preparing the same. | 2012-04-19 |
20120093928 | ORAL METAXALONE COMPOSITIONS - The present invention relates to a pharmaceutical composition comprising low-dose metaxalone and one or more pharmaceutically acceptable polymer, as well as methods of preparing them. | 2012-04-19 |
20120093930 | ARTICLE AND METHOD FOR FOCUSED DELIVERY OF THERAPEUTIC AND/OR DIAGNOSTIC MATERIALS - A microfiber extrudate and delivery process includes a bio-compatible polymer matrix forming a body of the microfiber extrudate, an exogenously excitable material arranged within the body, and an active load arranged within the body. | 2012-04-19 |
20120093931 | Inhibition of Neovascularization by Cerium Oxide Nanoparticles - The present invention provides methods for reducing, reversing or inhibiting neovascularization in a tissue of a mammalian subject having a pathological condition involving neovascularization by administration in vivo of nanoceria particles (cerium oxide nanoparticles) to the subject. The method of the invention is useful, for example, for reducing, treating, reversing or inhibiting neovascularization in ocular tissue such as the retina, macula or cornea; in skin; in synovial tissue; in intestinal tissue; or in bone. In addition, the method of the invention is useful for reducing or inhibiting neovascularization in a neoplasm (tumors), which can be benign or malignant and, where malignant, can be a metastatic neoplasm. As such, the invention provides compositions, which contain nanoceria particles and are useful for reducing, treating, reversing or inhibiting angiogenesis in a mammalian subject. | 2012-04-19 |
20120093932 | TARGETED SUSTAINED-RELEASE MICROSPHERE OF VASCULAR OCCLUSIVE AGENT CONTAINING SODIUM ALGINATE AND SORAFENIB, PRODUCTION METHOD AND USE THEREOF - A targeted sustained-release microsphere vascular embolizing agent, the production method and the use thereof are disclosed. The microsphere comprises sodium alginate as the carrier and sorafenib as the targeted anti-tumor medicine and sorafenib is encapsulated by sodium alginate. The weight ratio of sorafenib to sodium alginate is 1:1˜1:30. The microspheres are used for manufacturing medicament for the treatment of solid tumors with advantages including high medicine concentration in the target regions with reduced systemic dosage and toxic and side effects. | 2012-04-19 |
20120093933 | DENATURED LACTOGLOBULIN AND POLYPHENOL COASSEMBLIES - The present invention is directed to co-assembled nanoparticle composition comprising denatured β-lactoglobulin and at least one nutraceutical compound, specifically polyphenols, such as EGCG, compositions comprising same and methods of preparing thereof. | 2012-04-19 |
20120093934 | METHODS FOR TREATING AUTOIMMUNE DISEASE USING BIOCOMPATIBLE BIOABSORBABLE NANOSPHERES - The methods include selectively reducing or expanding T cells according to the antigenic specificity of the T cells using biocompatible bioabsorbable nanospheres. Therefore, the present invention can be used to reduce or eliminate pathogenic T cells that recognize autoantigens, such as beta cell specific T cells. As such, the present invention can be used to prevent, treat or ameliorate autoimmune diseases such as IDDM. Furthermore, the present invention can be used to expand desirable T cells, such as anti-pathogenic T cells to prevent, treat and/or ameliorate autoimmune diseases. | 2012-04-19 |
20120093935 | PARTICLES HAVING A LUMINESCENT INORGANIC SHELL, METHOD FOR COATING PARTICLES AND USE THEREOF - The invention relates to a method for coating particles with a luminescent inorganic shell. Furthermore, the invention relates to particles having a luminescent inorganic shell and also use thereof. | 2012-04-19 |
20120093936 | METHOD AND DEVICE FOR TREATMENT OF CONDITIONS ASSOCIATED WITH INFLAMMATION OR UNDESIRABLE ACTIVATION OF THE IMMUNE SYSTEM - The present invention relates to methods and compositions for use in the treatment of specific medical conditions. The compositions of the invention comprise blood serum preparations, such as activated blood serum preparations. The present invention also relates to the use of such blood serum preparations for the treatment of diseases and disorders associated with inflammation and/or undesirable activation of the immune system, such as paradentosis, abortus habitualis, colitis ulcerosa, polymyalgia rheumatica, whiplash-associated disorders, endometriosis, adeomyosis and unexplained infertility. | 2012-04-19 |
20120093937 | ENCAPSULATED LIVER CELL COMPOSITION - Microcapsules including a capsule shell encapsulating a suspension of a therapeutically effective amount of liver cells in physical contact with a liver cell stimulating amount of erythropoietin. | 2012-04-19 |
20120093938 | ORALLY DISINTEGRATING TABLETS COMPRISING DIPHENHYDRAMINE - The compositions of the present invention comprise a therapeutically effective amount of particles consisting of diphenhydramine or pharmaceutically acceptable salts thereof, optionally in combination with another drug such as pseudoephedrine, or phenylephrine and hydrocodone, in combination with rapidly-dispersing microgranules comprising a disintegrant and a sugar alcohol and/or a saccharide. These compositions are useful in treating the symptoms of one or more diseases or conditions in which diphenhydramine (alone or in combination with one or two other drugs) is a therapeutically effective, e.g. allergic rhinitis, sinusitis, upper respiratory tract infections, motion sickness, Parkinson's disease, insomnia, the common cold, and nighttime pain management, particularly for subjects or patients with dysphagia, and people ‘on the move’. | 2012-04-19 |
20120093939 | ORAL FORMULATIONS - Disclosed are pharmaceutical compositions comprising immediate release and sustained release formulations of 5-aminosalicylic acid, or a pharmaceutically acceptable salt or ester thereof, and/or N-acetylcysteine, or a pharmaceutically acceptable salt or ester thereof, for release in the lower gastrointestinal tract. | 2012-04-19 |
20120093940 | MEDICAL FOOD OR NUTRITIONAL SUPPLEMENT FOR MANAGING BLOOD GLUCOSE LEVELS AND METHOD OF MANUFACTURING SAME - A medical food and/or nutritional supplement for oral administration by mammals includes α-lipoic acid, linolenic acid complex, biotin, and coenzyme Q-10. A preferred method of manufacturing the medical food or nutritional supplement is by separate microencapsulation of one or more of the components followed by encapsulation of the individual components, for oral administration. Other methods of delivery include packaging in impermeable, disposable packets and mixing the formulations with food or a cold liquid. | 2012-04-19 |
20120093941 | NEUTROPHIL-DEPLETED PLATELET RICH PLASMA FORMULATIONS FOR CARDIAC TREATMENTS - Compositions and methods for preparing neutrophil-depleted platelet rich plasma are provided. Generally, these compositions comprise a higher concentration of platelets and depressed concentrations of neutrophils relative to whole blood although white blood cells may be at higher concentrations than whole blood. The concentrations of the platelets and/or the white blood cells may be two to eight times the respective concentrations in whole blood. These compositions may have depressed concentrations of red blood cells and hemoglobin. In some variations, the compositions may be useful to treat damaged connective tissue and/or to slow or stop cardiac apoptosis after a heart attack. The neutrophil-depleted platelet rich plasma composition may be delivered in conjunction with reperfusion therapy. | 2012-04-19 |
20120093942 | PHARMACEUTICAL COMPOSITION FOR TREATING NEPHROPATHY AND HEALTHY FOOD COMPRISING HERB EXTRACTS - Disclosed is a pharmaceutical composition and health food comprising herb extracts of one or more herbs selected from the group consisting of Puerariae Radix, Bombycis corpus and Araliae Continentalis Radix. The herb medicine of this invention comprising a single or mixed composition may be useful for the prevention and treatment of renal diseases as well as improvement of renal functions. | 2012-04-19 |
20120093943 | PHARMACEUTICALLY ACTIVE COMPOUNDS, THEIR MANUFACTURE, COMPOSITIONS CONTAINING THEM, AND THEIR USE - A substance for use as a medicament, comprises a solid mixed metal compound of formula (I): M | 2012-04-19 |
20120093944 | Method for surface inclusions detection, enhancement of endothelial and osteoblast cells adhesion and proliferation, sterilization of electropolished and magnetoelectropolished nitinol surfaces - The method for surface inclusions detection, enhancement of endothelial and osteoblast cells adhesion and proliferation and sterilization of electropolished and magnetoelectropolished Nitinol implantable medical device surfaces uses an aqueous solution of chemical compounds containing halogenous oxyanions as hypochlorite (ClO | 2012-04-19 |
20120093945 | METHOD FOR TREATING AN INFLAMMATION OR LESION CAUSED BY A VIRUS - A method for treating an inflammation or lesion caused by herpes virus, comprising topically applying to said inflammation or lesion a composition consisting essentially of a C | 2012-04-19 |
20120093946 | USE OF CARBON DIOXIDE SUPPLYING MEANS FOR MUSCLE STRENGTHENING AND METHOD OF INCREASING CATTLE MEAT THEREBY - Use of a carbon dioxide-supplying means for muscle strengthening makes it possible conveniently to strengthen a target muscle within a short period of time merely by allowing the target site to absorb carbon dioxide without loading any mechanical burden on the target muscle. By loading a mechanical burden on the target muscle, the muscle strengthening effect can be further enhanced and an additional effect of promoting the recovery from muscle fatigue can be achieved owing to the mechanical burden. By using the carbon dioxide-supplying means for muscle strengthening as described above, it is also possible to increase cattle meat. | 2012-04-19 |
20120093947 | METHOD OF TREATING REACTIVE AIRWAY DISEASE - A method of treating a reactive airway disease in a subject comprising administering at least one peroxidase inhibitor in association with administration of at least one β-agonist. | 2012-04-19 |
20120093948 | Nitric Oxide Treatments - Portable and pure nitric oxide delivery systems can be used to treat a variety of patient conditions. | 2012-04-19 |
20120093949 | SYSTEMS AND METHODS FOR TREATING LICE - A method of treating lice includes the steps of: (a) blending a treatment mixture; (b) applying the treatment mixture to a scalp or hair; and (c) applying a first shampoo to the scalp or the hair. The treatment mixture used in this method may contain olive oil and dimethicone. The lice treatment mixture may further contain between about 2 and 6 drops of rosemary oil. In yet another embodiment the lice treatment mixture may still further contain at least one of the following ingredients: beeswax, vitamin E, citronella oil, tea tree oil, eucalyptus oil, mint oil, coconut oil, peppermint oil, and lavender oil. | 2012-04-19 |
20120093951 | TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING SWINE INFLUENZA, PREPARATION METHOD AND USE THEREOF - The present invention relates to a traditional Chinese medicine composition for preventing and treating swine influenza, preparation method and use thereof. The said traditional Chinese medicine composition is made from | 2012-04-19 |
20120093952 | USE OF ESSENTIAL OIL COMPOUNDS AS HISTOMONASTAT - The present invention relates to the use of essential oil compounds as histomonastats. An example of a essential oil compound of the invention is cinnamaldehyde. | 2012-04-19 |
20120093953 | Magnolia Extract Containing Compositions - Disclosed is a method of treating telangiectasias on a person's skin comprising topically applying to skin in need of treatment a composition comprising magnolia bark extract. | 2012-04-19 |
20120093954 | COMPRESSION MOLDING METHOD FOR ELECTRONIC COMPONENT AND COMPRESSION MOLDING APPARATUS EMPLOYED THEREFOR - First, a horizontal nozzle is inserted between an upper mold section and a lower mold section in a horizontally extending state. Then, liquid resin is horizontally discharged from a discharge port of the horizontal nozzle. Thus, the liquid resin is supplied into a cavity. Thereafter the upper mold section and the lower mold section are closed. Consequently, an electronic component mounted on a substrate is dipped in the liquid resin stored in the cavity. Therefore, the electronic component is resin-sealed on the substrate by compression molding. | 2012-04-19 |
20120093955 | ADJUSTABLE ALIGNING DEVICE FOR LARGE COMPOSITE MOULDS - An adjustable aligning device ( | 2012-04-19 |
20120093956 | Housing Support For An Apparatus Used For Providing Packaging Material - Disclosed is a housing support for an apparatus that is used for providing packaging material. A device for shaping the packaging material in order to form filling material this is discharged at an outlet of the housing support is rotatably mounted on the housing support. The housing support comprises a hopper on which a holder for a packaging material reservoir can be mounted and via which the packaging material is fed to the shaping device, a discharge orifice that delimits the outlet, and a bearing structure which is arranged between the hopper and the discharge port in the feeding direction and on which the shaping device can be rotated. The hopper, the discharge port, and the bearing structure are arranged to rest against each other in such a way that a continuous feeding path encompassing an especially rectilinear axis of the feeding direction is formed through the housing support. The feeding path is delimited by an interior wall in the region of the hopper and the discharge port, said interior wall continuously extending around the axis of the feeding direction. In said housing support, (a) at least one concavity that laterally extends away form the feeding path is provided in the region of a central interior wall of the bearing structure, said central interior wall delimiting the feeding path, (b) the concavity runs into the feeding path at a slit that is formed within the central interior wall, (c) the concavity holds the shaping device that is rotatably mounted on the bearing structure in such a way that the shaping device partially projects from the slit into the feeding path in order to shape the packaging material, and (d) the shape of the slit is complementary to the shape of a section of the shaping device adjoining the slit such that a tolerance gap is formed which allows the shaping device to rotate relative to the stationary bearing structure without entering in contact therewith. | 2012-04-19 |
20120093957 | ELECTRIC MOTOR DRIVE UNIT FOR AN INJECTION MOLDING MACHINE FOR PROCESSING PLASTICS - The invention relates to an injection molding unit for an injection molding machine for processing plastics, comprising an electro-mechanical dosing motor (D) for rotating a worm conveyor ( | 2012-04-19 |
20120093958 | Ice Cream Scoop - An ice cream scoop includes a handle, a scooper coupled to an end of the handle, a scraper installed in the scooper, a link rod extended from an end of the scraper into the end of the handle, and a transmission device installed on the link rod. The ice cream scoop further includes an operating device with an end pivotally coupled to the handle, such that the operating device can be swayed between a first position and a second position with respect to the handle. The operating device further includes a driving portion coupled to the transmission device. If the operating device is swayed between the first and second positions, the link rod will be rotated, and the scraper will be moved along an internal wall of the scooper. | 2012-04-19 |
20120093959 | APPARATUS FOR VACUUM FOAMING CONTAINERS FOR REFRIGERATION - An apparatus for vacuum foaming containers for refrigeration of foodstuffs, in which a polyurethane mixture is injected into hollow walls of a container closed under vacuum condition within a foaming cell. The apparatus includes a main frame for supporting the foaming cell, and an auxiliary frame movable between a lowered opening position and raised closing position of the foaming cell. The foaming cell includes a pallet for supporting a container to be foamed, side shore panels, transversal shore panels, and an internal shore plug member supported by the main frame. The side panels are hingedly connected to slides transversally movable with respect to the auxiliary frame for enabling their distance to be adjusted. | 2012-04-19 |
20120093960 | Press Plate Actuating System - The present invention is related to a press plate actuating system, particularly for driving a lower thermoforming plate ( | 2012-04-19 |
20120093961 | MOULD HAVING MOVABLE MOLD INSERT - Provided is a mould having movable mold insert, including a male mold, a female mold, a movable mold insert and a mold insert positioning mechanism. The female mold is located just above the male mold and disposes a plurality of core pins. The movable mold insert is movable connected to the male mold. The movable mold insert disposes a plurality of inserting holes corresponding to the core pins. The mold insert positioning mechanism includes a positioning hole and a positioning post matched with the positioning hole. The positioning hole is formed on the movable mold insert, and the positioning post is fixed to the female mold. A protruding length from the bottom surface of the female mold, of the positioning post, is larger than that of the core pins. The mould of the present invention can protect the movable mold insert and greatly improve the product quality. | 2012-04-19 |
20120093962 | MOTIF-ARRAYING APPARATUS - The present invention relates to a motif-arraying apparatus for arraying motifs such as a hot fix or the like in mounting grooves formed in a mold plate. The present invention provides a motif-arraying apparatus comprising a shaking member for loading motifs in the mounting grooves formed in the mold plate, wherein said shaking member includes a vertical board and a horizontal board coupled to an edge thereof, and a plurality of shaking knives coupled to the bottom surface of the vertical board at a predetermined interval. Thus, the apparatus of the present invention not only enables motifs to be correctly arrayed in the mounting grooves formed in the mold plate in a quick and easy manner, but also enables a motif inserted in a wrong direction to be removed from the mounting groove and correctly arrayed, thereby improving productivity, minimizing defects, and reducing costs. | 2012-04-19 |
20120093963 | METHOD AND APPARATUS FOR MAKING CANDLES, VASES OR DECORATIVE OBJECTS - Making candles, vases or ornamental articles, by rotating a mold in elevation and azimuth, pouring wax into the mold, allowing the wax to partially or completely harden, and repeating these steps to build up layers of wax in different inclined planes. Apparatus is described for carrying out this method, having a support rotatable in elevation and a mold holder rotatable in azimuth on the support. An alternative apparatus is described having a vessel that may be optionally temperature controlled and containing flowable material supporting a mold. Further apparatus is described having means to support a mold at variable angles of elevation and azimuth. The apparatus and materials for carrying out the method may be supplied as a kit, with the apparatus either fully assembled or supplied as separate parts to be assembled by the user. | 2012-04-19 |
20120093964 | MOULD CLAMPING SYSTEM - A mould clamping system ( | 2012-04-19 |
20120093965 | BLOW NOZZLE TO CONTROL LIQUID FLOW WITH PRE-STRETCH ROD ASSEMBLY - An apparatus for forming a container comprising a housing and a rod apparatus disposed in the housing. The rod apparatus includes a rod for at least partially forming a container preform. The apparatus further includes a nozzle system disposed in the housing that is operably coupled with the rod apparatus. The nozzle system is positionable between a first position preventing pressurized fluid from being injected into the container preform and a second position permitting pressurized fluid to be injected into the container preform. | 2012-04-19 |
20120093966 | APPARATUSES AND METHODS FOR MANUFACTURING CONTAINERS - Apparatus, comprising a rotating carousel and a plurality of handling elements supported by said carousel and movable in relation to said carousel, said handling elements being so shaped as to remove a container from a blow-moulding mould arrangement, wherein said apparatus further comprises a plurality of further handling elements associated with said handling elements, said further handling elements being so shaped as to deliver a dose of plastics to a compression-moulding mould arrangement, each of said further handling elements being fixed to a corresponding handling element. | 2012-04-19 |
20120093967 | INSERT MOLDING - Disclosed is an insert molding employed to form a plastic product with an insert. The insert has an inserting unit and an extending unit. The insert molding comprises a cope plate, a lower die and a holding mechanism. The cope plate is formed with a cavity. The extending unit dips into the cavity. The holding mechanism is installed on the lower die to hold the extending unit of the insert. When the insert molding of the present invention is opened, the holding mechanism can hold the extending unit of the insert to prevent the plastic product sticking to the cope plate. Accordingly, it is capable to prevent the plastic product crushed when the insert molding is closed again. | 2012-04-19 |
20120093968 | HYDRAULIC DRIVE CIRCUIT WITH PARALLEL ARCHITECTURED ACCUMULATOR - A hydraulic circuit architecture for use in a drive circuit having a hydraulic pump for driving a load is disclosed. The hydraulic circuit architecture includes a flow control valve for controlling a hydraulic fluid flow rate supplied from the hydraulic pump to the load. The hydraulic circuit architecture also includes a hydraulic fluid accumulator arranged in parallel with respect to the flow control valve. Hydraulic circuit architectures having multiple accumulators arranged in parallel with respect to the flow control valve are also disclosed. | 2012-04-19 |
20120093969 | BIRDSEED FORMULATIONS FOR ATTRACTING DESIRABLE BIRDS FROM THE MIDWESTERN REGION OF THE UNITED STATES - Birdseed blends are formulated to attract desirable birds that generally reside in the Midwestern Region and other similar regions of the United States. Such birdseed formulations may attract more birds than conventional black oil sunflower seeds alone or conventional birdseed mixes. In addition, such birdseed formulations also may generally attract more desirable birds than black oil sunflower seeds or conventional birdseed mixes, while attracting less undesirable birds. | 2012-04-19 |
20120093970 | BIRDSEED FORMULATIONS FOR ATTRACTING DESIRABLE BIRDS FROM THE SOUTHERN REGION OF THE UNITED STATES - Birdseed blends are formulated to attract desirable birds that generally reside in the Southern Region and other similar regions of the United States. Such birdseed formulations may attract more birds than conventional black oil sunflower seeds alone or conventional birdseed mixes. In addition, such birdseed formulations also may generally attract more desirable birds than black oil sunflower seeds or conventional birdseed mixes, while attracting less undesirable birds. | 2012-04-19 |